135 related articles for article (PubMed ID: 17065663)
21. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
[TBL] [Abstract][Full Text] [Related]
22. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
Marcil M; Boucher B; Gagné E; Davignon J; Hayden M; Genest J
J Lipid Res; 1996 Feb; 37(2):309-19. PubMed ID: 9026529
[TBL] [Abstract][Full Text] [Related]
23. Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice.
Wu S; Mar-Heyming R; Dugum EZ; Kolaitis NA; Qi H; Pajukanta P; Castellani LW; Lusis AJ; Drake TA
Hum Mol Genet; 2010 Feb; 19(4):597-608. PubMed ID: 19995791
[TBL] [Abstract][Full Text] [Related]
24. Role of insulin resistance in familial combined hyperlipidemia.
Veerkamp MJ; de Graaf J; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
[TBL] [Abstract][Full Text] [Related]
25. The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia.
van der Vleuten GM; Kluijtmans LA; Hijmans A; Blom HJ; Stalenhoef AF; de Graaf J
Int J Obes (Lond); 2006 Jun; 30(6):892-8. PubMed ID: 16432543
[TBL] [Abstract][Full Text] [Related]
26. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
Dallinga-Thie GM; van Linde-Sibenius Trip M; Rotter JI; Cantor RM; Bu X; Lusis AJ; de Bruin TW
J Clin Invest; 1997 Mar; 99(5):953-61. PubMed ID: 9062353
[TBL] [Abstract][Full Text] [Related]
27. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia.
de Graaf J; van der Vleuten G; Stalenhoef AF
Semin Vasc Med; 2004 Aug; 4(3):229-40. PubMed ID: 15630632
[TBL] [Abstract][Full Text] [Related]
29. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
Plaisier CL; Horvath S; Huertas-Vazquez A; Cruz-Bautista I; Herrera MF; Tusie-Luna T; Aguilar-Salinas C; Pajukanta P
PLoS Genet; 2009 Sep; 5(9):e1000642. PubMed ID: 19750004
[TBL] [Abstract][Full Text] [Related]
30. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.
Bredie SJ; Kiemeney LA; de Haan AF; Demacker PN; Stalenhoef AF
Am J Hum Genet; 1996 Apr; 58(4):812-22. PubMed ID: 8644746
[TBL] [Abstract][Full Text] [Related]
31. The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population.
Ng MC; Miyake K; So WY; Poon EW; Lam VK; Li JK; Cox NJ; Bell GI; Chan JC
Diabetologia; 2005 Oct; 48(10):2018-24. PubMed ID: 16132950
[TBL] [Abstract][Full Text] [Related]
32. Upstream transcription factor 1 (USF1) in risk of type 2 diabetes: association study in 2000 Dutch Caucasians.
Meex SJ; van Vliet-Ostaptchouk JV; van der Kallen CJ; van Greevenbroek MM; Schalkwijk CG; Feskens EJ; Blaak EE; Wijmenga C; Hofker MH; Stehouwer CD; de Bruin TW
Mol Genet Metab; 2008 Jul; 94(3):352-5. PubMed ID: 18445538
[TBL] [Abstract][Full Text] [Related]
33. Common polymorphisms in the USF1 gene are not associated with type 2 diabetes in French Caucasians.
Gibson F; Hercberg S; Froguel P
Diabetes; 2005 Oct; 54(10):3040-2. PubMed ID: 16186412
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.
Allayee H; Castellani LW; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2003 Jun; 92(11):1262-7. PubMed ID: 12738753
[TBL] [Abstract][Full Text] [Related]
35. Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Holzapfel C; Baumert J; Grallert H; Müller AM; Thorand B; Khuseyinova N; Herder C; Meisinger C; Hauner H; Wichmann HE; Koenig W; Illig T; Klopp N
Eur J Endocrinol; 2008 Oct; 159(4):407-16. PubMed ID: 18593823
[TBL] [Abstract][Full Text] [Related]
36. Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1q.
Zeggini E; Damcott CM; Hanson RL; Karim MA; Rayner NW; Groves CJ; Baier LJ; Hale TC; Hattersley AT; Hitman GA; Hunt SE; Knowler WC; Mitchell BD; Ng MC; O'Connell JR; Pollin TI; Vaxillaire M; Walker M; Wang X; Whittaker P; Xiang K; Jia W; Chan JC; Froguel P; Deloukas P; Shuldiner AR; Elbein SC; McCarthy MI;
Diabetes; 2006 Sep; 55(9):2541-8. PubMed ID: 16936202
[TBL] [Abstract][Full Text] [Related]
37. Body mass index is associated with USF1 haplotype in Korean premenopausal women.
Lee SK; Kim HJ; Kim BJ; Jo YS; Park KS; Baik HW; Hyun SH; Lee JC; Kim SA
J Korean Med Sci; 2008 Feb; 23(1):83-8. PubMed ID: 18303204
[TBL] [Abstract][Full Text] [Related]
38. A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia.
Huertas-Vazquez A; Plaisier CL; Geng R; Haas BE; Lee J; Greevenbroek MM; van der Kallen C; de Bruin TW; Taskinen MR; Alagramam KN; Pajukanta P
Hum Genet; 2010 Jan; 127(1):83-9. PubMed ID: 19816713
[TBL] [Abstract][Full Text] [Related]
39. Allelic variants of upstream transcription factor 1 associate with carotid artery intima-media thickness: the Cardiovascular Risk in Young Finns study.
Collings A; Höyssä S; Fan M; Kähönen M; Hutri-Kähönen N; Marniemi J; Juonala M; Viikari JS; Raitakari OT; Lehtimäki TJ
Circ J; 2008 Jul; 72(7):1158-64. PubMed ID: 18577828
[TBL] [Abstract][Full Text] [Related]
40. Thioredoxin interacting protein in Dutch families with familial combined hyperlipidemia.
van der Vleuten GM; Hijmans A; Kluijtmans LA; Blom HJ; Stalenhoef AF; de Graaf J
Am J Med Genet A; 2004 Sep; 130A(1):73-5. PubMed ID: 15368498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
